Show simple item record

dc.contributor.authorTiemersma, Edine
dc.contributor.authorvan den Hof, Susan
dc.contributor.authorDravniece, Gunta
dc.contributor.authorWares, Fraser
dc.contributor.authorMolla, Yohannes
dc.contributor.authorPermata, Yusie
dc.contributor.authorLukitosari, Endang
dc.contributor.authorQuelapio, Mamel
dc.contributor.authorAung, Si Thu
dc.contributor.authorAung, Khay Mar
dc.contributor.authorThuy, Hoang Thanh
dc.contributor.authorHoa, Vu Dinh
dc.contributor.authorSulaimanova, Merkinai
dc.contributor.authorSagyndikova, Saadat
dc.contributor.authorMakhmudova, Mavluda
dc.contributor.authorSoliev, Alijon
dc.contributor.authorKimerling, Michael
dc.date.accessioned2019-10-21T20:49:44Z
dc.date.available2019-10-21T20:49:44Z
dc.date.issued2019-09-30
dc.identifier.issn1600-0617
dc.identifier.pmid31604816
dc.identifier.doi10.1183/16000617.0115-2018
dc.identifier.urihttp://hdl.handle.net/10029/623403
dc.language.isoenen_US
dc.titleIntegration of drug safety monitoring in tuberculosis treatment programmes: country experiences.en_US
dc.typeArticleen_US
dc.identifier.journalEur Respir Rev 2019; 28(153):pii.108115en_US
dc.source.journaltitleEuropean respiratory review : an official journal of the European Respiratory Society


This item appears in the following Collection(s)

Show simple item record